Current reimbursement arrangements are undermining the National Medicines Policy, according to Medicines Australia CEO, Tim James, while companies have used the Senate inquiry to restate their criticisms of PBS processes.
Latest Video
New Stories
-
Lundbeck scores again and achieves certification as a 'Great Place to Work'
June 17, 2024 - - Latest News -
It might sound like a lot, but are these officeholders paid enough?
June 17, 2024 - - Latest News -
New report reveals the economic contribution of clinical trials but warns of stagnation
June 16, 2024 - - Latest News -
TGA extends the use of Bayer contraceptive to eight years
June 16, 2024 - - Latest News -
Research Australia challenges draft immunisation strategy over major omissions
June 14, 2024 - - Latest News -
The 'Week in Review' Podcast - 14 June
June 13, 2024 - - Podcast -
Competition regulator outlines "preliminary competition concerns" on CW-Sigma merger
June 13, 2024 - - Latest News